Home
ODC vs MRUS Comparison

ODC vs MRUS Comparison

Compare ODC & MRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ODC

MRUS

Machine Learning Prediction

ML Decision
ODC
MRUS

Stock Information

Founded
ODC 1941
MRUS 2003

Country
ODC United States
MRUS Netherlands

Employees
ODC N/A
MRUS N/A

Industry
ODC Miscellaneous manufacturing industries
MRUS Biotechnology: Pharmaceutical Preparations

Sector
ODC Consumer Discretionary
MRUS Health Care

Exchange
ODC Nasdaq
MRUS Nasdaq

Market Cap
ODC N/A
MRUS 2.7B

IPO Year
ODC N/A
MRUS 2016

Fundamental

Price
ODC $46.41
MRUS $43.01

Analyst Decision
ODC
MRUS Strong Buy

Analyst Count
ODC 0
MRUS 13

Target Price
ODC N/A
MRUS $86.85

AVG Volume (30 Days)
ODC 53.2K
MRUS 711.2K

Earning Date
ODC 03-11-2025
MRUS 05-07-2025

Dividend Yield
ODC 1.35%
MRUS N/A

EPS Growth
ODC 18.90
MRUS N/A

EPS
ODC 3.13
MRUS N/A

Revenue
ODC $465,340,000.00
MRUS $36,133,000.00

Revenue This Year
ODC N/A
MRUS $37.72

Revenue Next Year
ODC N/A
MRUS $48.47

P/E Ratio
ODC $14.88
MRUS N/A

Revenue Growth
ODC 8.24
MRUS N/A

52 Week Low
ODC $29.48
MRUS $37.77

52 Week High
ODC $49.72
MRUS $61.61

Technical

Relative Strength Index (RSI)
ODC 52.18
MRUS 44.45

Support Level
ODC $44.75
MRUS $39.00

Resistance Level
ODC $46.93
MRUS $45.44

Average True Range (ATR)
ODC 1.50
MRUS 2.61

MACD
ODC -0.25
MRUS -0.82

Stochastic Oscillator
ODC 39.09
MRUS 40.44

Stock Price Comparison Chart: ODC vs MRUS

■ ODC

■ MRUS

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use